HR 5997
115th Congress
House
Health
Administrative remedies
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government studies and investigations
Health information and medical records
Health technology, devices, supplies
Home and outpatient care
Hospital care
Medicare
Ensuring Patient Access to Critical Breakthrough Products Act of 2018
Introduced: June 5, 2018
Introduced by:
DelBene, Suzan K.
Democratic
· Washington
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 8, 2018
Referred to the Subcommittee on Health.
Jun 5, 2018
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 5, 2018
Introduced in House
Plain-English summary
Ensuring Patient Access to Critical Breakthrough Products Act of 2018
This bill (1) allows designated medical breakthrough devices to be temporarily covered under Medicare during a specified transitional period, (2) establishes a process to allow for continued coverage after the transitional period has expired, and (3) modifies other Medicare payment systems relating to new medical technology.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3